Link William J PhD's Form 4 filing
Tarsus Pharmaceuticals, Inc. (TARS) · filed Mar 18, 2026
- Accession no.
- 0001228684-26-000002
- Filed
- Mar 18, 2026
- Trade date
- Mar 16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $859.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Link William J PhDCIK 0001228684 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Common Stock | SSaleDisposed | −3,629 | $68.09 | −$247,098.61 | 125,203 | Direct | |
| Mar 16, 2026 | Common Stock | SSaleDisposed | −8,378 | $69.03 | −$578,333.34 | 116,825 | Direct | |
| Mar 16, 2026 | Common Stock | SSaleDisposed | −493 | $69.75 | −$34,386.75 | 116,332 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.